Counterforce Health (Page 13)

More issues

How to Get Kesimpta (Ofatumumab) Covered by Blue Cross Blue Shield in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Kesimpta Covered by BCBS Virginia Anthem Blue Cross Blue Shield Virginia classifies Kesimpta (ofatumumab) as a non-preferred specialty drug requiring prior authorization and step therapy. To get covered, you need: (1) documented relapsing MS diagnosis with recent activity, (2) failure of at least 2 preferred first-line DMTs,

How to Get Translarna (Ataluren) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Translarna (Ataluren) Covered by Aetna CVS Health in Pennsylvania Current Status: Translarna (ataluren) lacks FDA approval as of late 2024, so Aetna CVS Health typically denies coverage for nonsense mutation Duchenne muscular dystrophy (DMD) in Pennsylvania. However, you can still pursue coverage through prior authorization with medical

How to Renew Entresto (Sacubitril/Valsartan) Coverage with Cigna in Pennsylvania: Timing, Documents, and Appeals

Answer Box Renewing Entresto (sacubitril/valsartan) with Cigna in Pennsylvania requires proactive planning 30-60 days before your current authorization expires. Submit renewal requests through CoverMyMeds or call 1-800-882-4462. Include updated lab results (renal function, potassium), current dosing (target 97/103 mg BID), and clinical response documentation. If coverage lapses, Pennsylvania&

How to Get Uptravi (Selexipag) Covered by Aetna (CVS Health) in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Uptravi (Selexipag) Covered by Aetna (CVS Health) in Washington Aetna (CVS Health) requires prior authorization for Uptravi (selexipag) with documented WHO Group I PAH confirmed by right heart catheterization (mPAP >20 mmHg, PCWP ≤15 mmHg), WHO functional class II-IV, and step therapy showing failure of at

Myths vs. Facts: Getting Mepsevii (Vestronidase Alfa-vjbk) Covered by Humana in Virginia

Quick Answer: Your Path to Mepsevii Coverage Humana requires prior authorization for Mepsevii (vestronidase alfa-vjbk) in Virginia, but approval is possible with confirmed MPS VII diagnosis and specialist documentation. Submit genetic testing results, enzyme assay, and medical necessity letter from a metabolic specialist. Standard decisions take 7-30 days; expedited reviews

Getting Rinvoq (Upadacitinib) Covered by Cigna in New York: PA Forms, Step Therapy Rules, and Appeals Guide

Answer Box: Your Path to Rinvoq Coverage in New York To get Rinvoq (upadacitinib) covered by Cigna in New York, you'll need prior authorization with documented failure or intolerance of at least one TNF inhibitor (like Humira, Enbrel, or Remicade) for most conditions. Submit your PA electronically via

The Complete Guide to Getting Cosentyx (Secukinumab) Covered by Humana in Georgia: Prior Authorization, Appeals & Success Strategies

Answer Box: Your Path to Cosentyx Coverage To get Cosentyx (secukinumab) covered by Humana in Georgia: Submit a prior authorization request through CenterWell Specialty Pharmacy or your prescriber's portal within 72 hours of prescription. Include diagnosis codes (L40.0 for psoriasis, M07.0 for psoriatic arthritis, M45 for

Getting Cystadane (Betaine Anhydrous) Covered by Humana in Ohio: Complete Forms, Appeals & Timeline Guide

Answer Box: Fast Track to Cystadane Coverage Cystadane (betaine anhydrous) requires prior authorization from Humana for homocystinuria coverage. Your fastest path: 1) Have your prescriber submit the Request for Medicare Prescription Drug Coverage Determination form with genetic testing results and ICD-10 code E72.11, 2) Fax to 877-486-2621 or submit

How to Get Amvuttra (Vutrisiran) Covered by Cigna in Pennsylvania: Complete Coverage Criteria Guide

Answer Box: Fast Track to Amvuttra Coverage Cigna requires prior authorization for Amvuttra (vutrisiran) under Policy IP0478, with approval typically taking 5 business days when all criteria are met. To get coverage in Pennsylvania: (1) Confirm your TTR genetic testing results from a CLIA-certified lab, (2) gather baseline neuropathy documentation

Renewing Takhzyro (lanadelumab-flyo) Approval with Cigna in Washington: Complete Timeline & Documentation Guide

Answer Box: Takhzyro Renewal with Cigna in Washington Cigna requires renewal documentation 2-4 weeks before your current Takhzyro approval expires, typically after 6-12 months. Submit via Express Scripts with attack frequency logs showing ≥50% reduction, specialist attestation, and decreased on-demand therapy claims. If denied, Washington residents can appeal through internal